Buprenorphine Treatment in Pregnancy and Maternal-Infant Outcomes
In this cohort study of pregnant individuals with OUD, buprenorphine treatment was associated with improved outcomes for the mother and infant, underscoring the need to improve access to treatment nationwide.
Authors
- Ashley A. Leech (ORCID: https://orcid.org/0000-0001-6795-929X)
- Andrew David Wiese (ORCID: https://orcid.org/0000-0002-0699-4224)
- Thomas S. Reese (ORCID: https://orcid.org/0000-0002-1081-1670)
- Elizabeth McNeer
- Stephen W. Patrick (ORCID: https://orcid.org/0000-0001-6958-0371)
- Julia C. Phillippi (ORCID: https://orcid.org/0000-0002-6549-094X)
- William D. Dupont (ORCID: https://orcid.org/0000-0002-8166-599X)
- Judith A. Dudley
- Sarah F. Loch (ORCID: https://orcid.org/0000-0001-5500-4680)
- Sunaya R. Krishnapura
Institutions
- Emory University (US)
- Vanderbilt University (US)
- Vanderbilt University Medical Center (US)
Publication Details
- Journal
- JAMA Health Forum
- Published
- 2025-04-27
- DOI
- https://doi.org/10.1001/jamahealthforum.2025.1814
- Citations
- 4
- Primary Topic
- Prenatal Substance Exposure Effects
- Type
- article
- Field-Weighted Citation Impact
- 13.98
Funders
- Vanderbilt University
- Vanderbilt University Medical Center
- National Institutes of Health
- Health Resources and Services Administration
- Agency for Healthcare Research and Quality